Dividend Growth Stocks
STE is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
NYSE:STE • IE00BFY8C754
The current stock price of STE is 216.6 USD. Today STE is down by -1.43%. In the past month the price increased by 0.17%. In the past year, price decreased by -2.25%.
STE currently appears in the following ChartMill screener lists.
STE is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
STE occurs in the near 52-week low stock list, indicating it is a potential value opportunity.
STE is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
ChartMill assigns a technical rating of 1 / 10 to STE. When comparing the yearly performance of all stocks, STE is a bad performer in the overall market: 79.23% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to STE. Both the health and profitability get an excellent rating, making STE a very profitable company, without any liquidiy or solvency issues.
On February 4, 2026 STE reported an EPS of 2.53 and a revenue of 1.50B. The company missed EPS expectations (-1.09% surprise) and beat revenue expectations (0.01% surprise).
15 analysts have analysed STE and the average price target is 287.51 USD. This implies a price increase of 32.74% is expected in the next year compared to the current price of 216.6.
For the next year, analysts expect an EPS growth of 10.3% and a revenue growth 8.99% for STE
STE is currently included in the following stock indexes tracked on ChartMill.
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 10.08. The EPS increased by 9.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.15% | ||
| ROA | 6.68% | ||
| ROE | 9.89% | ||
| Debt/Equity | 0.27 |
STE operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 35 stocks and is scored by ChartMill on both price strength and growth momentum.
Each rank shows how many other sub-industries were outperformed over that timeframe.
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 38.97 | 165.737B | ||
| ABT | ABBOTT LABORATORIES | 14.73 | 163.098B | ||
| SYK | STRYKER CORP | 20.81 | 123.101B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.5 | 86.867B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.22 | 47.438B | ||
| IDXX | IDEXX LABORATORIES INC | 37.54 | 45.134B | ||
| BDX | BECTON DICKINSON AND CO | 10.75 | 42.574B | ||
| RMD | RESMED INC | 17.48 | 31.633B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 11.66 | 31.256B | ||
| DXCM | DEXCOM INC | 22.81 | 22.83B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.5 | 16.028B | ||
| PEN | PENUMBRA INC | 63.9 | 12.818B | ||
| PODD | INSULET CORP | 27.86 | 12.666B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
IPO: 2015-11-03
STERIS PLC
70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 17787
Phone: 35312322000
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
The current stock price of STE is 216.6 USD. The price decreased by -1.43% in the last trading session.
STERIS PLC (STE) has a dividend yield of 1.13%. The yearly dividend amount is currently 2.23.
STE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for STERIS PLC (STE) is 21.49. This is based on the reported non-GAAP earnings per share of 10.08 and the current share price of 216.6 USD.
The next ex-dividend date for STERIS PLC (STE) is February 17, 2026.
STERIS PLC (STE) has a market capitalization of 21.24B USD. This makes STE a Large Cap stock.